Debn
1 known investors
DEBN develops drug-eluting biopsy needles that deliver antibiotics directly to the prostate during transrectal ultrasound-guided biopsy procedures, reducing post-procedure infectious complications. The medical device targets urologists and healthcare systems performing prostate cancer diagnosis.
Deep TechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Debn do?
- DEBN develops drug-eluting biopsy needles that deliver antibiotics directly to the prostate during transrectal ultrasound-guided biopsy procedures, reducing post-procedure infectious complications. The medical device targets urologists and healthcare systems performing prostate cancer diagnosis.
- Who are Debn's investors?
- Debn's investors include Alfabeat.